The effects of 5% albumin and 4% gelatin solution on renal function, haemodynamic stability and blood loss in patient undergoing CABG (coronary artery bypass grafting in HUSM by Shahidan, Nur Zurairah
THE EFFECTS OF 5% ALBUMIN AND 4% GELATIN SOLUTION 
ON RENAL FUNCTION, HAEMODYNAMIC STABILITY AND 
BLOOD LOSS IN PATIENT UNDERGOING CABG (CORONARY 
ARTERY BYPASS GRAFTING) IN HUSM 
 
By: 
DR NUR ZURAIRAH BINTI SHAHIDAN 
DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF 
THE REQUIREMENTS FOR THE DEGREE OF MASTER OF 
MEDICINE (ANAESTHESIOLOGY)
 
 
UNIVERSITI SAINS MALAYSIA 
2017
i 
 
ACKNOWLEDGEMENT   
“In the name of ALLAH, the most Gracious and the most Merciful”. 
All praise is due for Allah, for providing me the strength and willingness to complete 
this work. 
I wish to express my gratitude to each contributor for this project would not have been 
possible without their support, input and guidance. 
I particularly would like to thank my mentor, supervisor and also the Head of the 
Department of Anaesthesiology and Intensive Care HUSM, AP Dr Saedah Ali; my co-
supervisor Prof Dr Nik Abdullah Nik Mohamad, AP Dr Mohamad Ziyadi Haji Ghazali , and 
to all lecturers for their teachings and encouragement throughout my course. Thanks to Dr 
Farzaana Adam for guiding me in analyzing the data. Also to friends, colleagues and hospital 
staffs for lending a helping hand in time of need especially the perfusionists and nurses in 
Cardiac Operation Theatre and Cardiac Intensive Care unit (CICU). 
My heartiest thanks go to my beloved husband and best friend, Rijal Faiz bin Abd 
Malek for his endless patience, encouragement and sacrifice has made completion of this 
study a reality.    
FUNDING/SUPPORT: Hospital University Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. 
 
 
 
 
 
ii 
 
TABLE OF CONTENT 
COVER PAGE 
PART 1: PRELIMINARIES 
1.1 ACKNOWLEDGEMENT           i 
1.2 TABLE OF CONTENT                 ii 
1.3 LIST OF TABLES          v 
1.4 LIST OF ABBREVIATION         vii 
1.5 ABSTRAK           ix 
1.6 ABSTRACT                     xi 
PART 2: MAIN DOCUMENT 
 2.1 TITLE PAGE           1 
 2.2 INTRODUCTION          2 
2.3 STUDY PROTOCOL         3 
2.3.1    Literature Review        3 
2.3.2 Objectives         5 
2.3.3 Null Hypothesis        5 
2.3.4  Research Design        6   
2.3.5  Inclusion and Exclusion Criteria      6  
2.3.6 Sample Size Estimation       6 
2.3.7 Sampling Method        7 
2.3.8 Study Area         7 
iii 
 
2.3.9 Research Tool        7 
2.3.10  Data Collection Method       8 
2.3.11   Proposed Data Analysis       10 
 2.4 BODY OF MANUSCRIPT  
  2.4.1 INTRODUCTION        11 
  2.4.2 METHODOLOGY        14 
  2.4.3 RESULTS         17 
  2.4.4 DISCUSSION         21 
  2.4.5 CONCLUSION        23 
2.4.6 REFERENCES                                         24 
2..4.7 TABLES REPRESENTING RESULTS OF THE STUDY           28 
  2.4.8  SELECTED JOURNAL FORMAT                36 
PART 3: REFERENCE MATERIAL and APPENDIXES                          
i. Letter for clarificatory interview at Human Research Ethics                             50 
 Committee USM (HREC)              
ii. Letter of amendment to USM HREC       51 
iii. Approval letter from USM HREC        52 
iv. GCP certificate             55 
v. Data collection form and consent form       56 
vi. List of computer generated randomisation sequence     78 
iv 
 
LIST OF TABLES                                                                                                  PAGE 
Table 1: Comparison of demographic characteristic between 5% albumin  
and 4% gelatin                                         28 
Table 2 : Mean difference of serum urea between  5% albumin  
and  4% gelatin           29 
Table 3 : Mean difference of serum creatinine between 5%  albumin  
and  4% gelatin group         29 
Table 4 : Comparison of  glomerular filtration rate (GFR) between  
5% albumin group and 4% gelatin group       30 
Table 5 :  Comparison of  Fractional Excretion of Sodium between 5%  
albumin group and 4% gelatin group       31 
Table 6: Comparison of intraoperative data between  5% albumin 
 group and 4% gelatin group         32 
Table 7 :  Mean cumulative fluid intake (colloid) and urine output 
 intraoperatively till day 2 post-operation, mean duration of cardiac intensive 
 care unit (CICU) and hospital stay       33 
Table 8 : Comparison of  the difference in GFR on  pre-operative and postoperative 
 day 3   between 5% albumin group and 4% gelatin group     33 
 
v 
 
Table  9 : Requirements of catecholamines and vasodilators in  
5% albumin group              34  
Table 10 : Requirements of catecholamines and vasodilators in 4% gelatin group     34 
Table 11 : Mean difference of intraoperative blood loss between 5% albumin   
 and  4% gelatin             35 
Table 12 : Mean difference of pre-operative and postoperative hemoglobin level                
between 5%  albumin group and 4% gelatin group solution       35 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF ABBREVIATION 
ACE inhibitor               Angiotensin converting enzyme inhibitor 
AKI                           Acute Kidney Injury 
ANOVA                     Analysis of Variance 
ASA                 American Society of Anaesthesiology 
BUSE        Blood Urea and Serum electrolytes 
CABG          Coronary Artery Bypass Grafting 
CICU      Cardiac Intensive Care Unit 
CKD                                         Chronic Kidney Disease 
CPB        Cardiopulmonary Bypass machine 
CrCl                 Creatinine Clearance 
CVP                 Central Venous Pressure 
FeNa        Fractional Excretion of Sodium 
FI02                 Fraction of Inhaled Oxygen 
FFP                   Fresh Frozen Plasma 
GFR        Glomerular Filtration Rate 
HES                 Hydroxyethyl Starch 
ICU                   Intensive Care Unit 
IL        Interleukin  
vii 
 
MAP                 Mean Arterial Blood Pressure 
NYHA                 New York Heart Association 
OT    Operation Theatre 
PCA                               Patient Controlled Analgesia 
POD1                Postoperative Day 1 
POD2     Postoperative Day 2 
POD3     Postoperative Day 3 
SD     Standard Deviation 
TNF    Tumor Necrosis Factor 
 
 
 
 
 
 
 
 
 
 
viii 
 
ABSTRAK 
Tajuk: Perbandingan kesan cecair 5% albumin dan 4% gelatin terhadap fungsi ginjal, 
kestabilan hemodinamik, dan jumlah kehilangan darah bagi pesakit yang menjalani 
pembedahan pintasan koronari jantung di Hospital Universiti Sains Malaysia. 
Latar Belakang dan Objektif: pilihan cecair terbaik untuk digunakan di dalam mesin 
„cardiopulmonary bypass‟ dan juga sewaktu pembedahan masih belum jelas. 
Tatacara Kajian: Tiga puluh empat pesakit yang menjalani pembedahan pintasan koronari 
jantung dikaji. Pesakit tidak akan dimasukkan ke dalam kajian ini sekiranya perlu menjalani 
pembedahan secara kecemasan, mengambil ubatan yang diketahui mengganggu fungsi ginjal, 
atau mengalami alahan kepada cecair jenis „colloid‟. Pesakit ditetapkan secara rawak ke 
dalam salah satu daripada kumpulan cecair „colloid‟ samada 5% albumin (n=18) atau 4% 
gelatin (n=16). Parameter hemodinamik, tahap kepekatan urea, creatinine, natrium di dalam 
darah dan air kencing di ambil sebelum pembedahan, sebaik sahaja selepas pembedahan, dan 
di hari pertama sehingga hari ketiga selepas pembedahan. Tahap hemoglobin juga diambil 
pada hari sebelum pembedahan, sebaik sahaja selepas pembedahan, hari pertama dan kedua 
selepas pembedahan. Keperluan pesakit kepada ubatan „cathecholamine‟ dan „vasodilator‟ 
juga direkodkan sehingga hari kedua selepas pembedahan. „Glomerular Filtration Rate‟, 
„Fractional Excretion of Sodium‟, dan jumlah kehilangan darah dikira dan dibandingkan..  
Keputusan: Purata perbezaan GFR nyata lebih tinggi di dalam kumpulan 4% Gelatin 
sepanjang tempoh kajian dijalankan namun FeNa tidak menunjukkan kesimpulan yang 
serupa. Purata tekanan darah semasa CPB mesin digunakan adalah nyata lebih tinggi di 
dalam kumpulan 5% Albumin (63.9±3.73mmHg) namun keperluan kepada ubatan 
„cathecholamine‟ dan „vasodilator‟ tidak jelas berbeza. Pesakit di dalam kumpulan 4% 
gelatin(1514.44±697.67mL) kehilangan darah lebih banyak daripada kumpulan 5% 
ix 
 
albumin(1425.3±451.81mL) namun perbezaan tersebut tidak signifikan. Sebanyak 22.2% 
pesakit di dalam kumpulan 5% albumin memerlukan transfuse darah berbanding 43.8% di 
dalam 4% gelatin. 
Kesimpulan: Pemberian cecair 5% albumin dan 4% gelatin ke atas pesakit yang menjalani 
pembedahan pintasan koronari tidak mempunyai kesan yang berbeza-beza dari segi fungsi 
ginjal, kestabilan hemodinamik dan kehilangan darah sewaktu pembedahan. 
 
Katakunci: Pintasan koronari, Albumin, Gelatin, Fungsi ginjal, kehilangan darah 
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ABSTRACT 
Background: The most ideal approach on cardiopulmonary bypass (CPB) priming and 
intravenous fluid choice during Coronary Artery Bypass Grafting (CABG) remains 
controversial. 
Methods: Thirty four patients undergoing elective CABG were studied. Patients were 
excluded if they scheduled for emergency CABG, on  known nephrotoxic drug or have a 
history of allergy to colloid. Patients were randomly assigned to two groups of 5% albumin 
(n=18) and 4% gelatin (n=16). Haemodynamic parameters, serum level of urea, creatinine, 
sodium and urine level of sodium and creatinine was measured preoperatively, immediately 
after the operation, day 1, 2 and 3 post-operatively. Hemoglobin level was taken 
preoperatively, immediately post-operation, day 1 and 2 after operation. Cathecolamines and 
vasodilator requirement was also recorded until day 2 post operation. Glomerular filtration 
rate (GFR), Fractional Excretion of Sodium (FeNa) was calculated and compared. 
 Results: mean difference of GFR was significantly higher in 4% gelatin group 
throughout the study but the FeNa difference was not statistically significant. On the topic of 
haemodynamic stability, the mean arterial blood pressure (MAP) during cardio pulmonary 
bypass was significantly higher in 5% albumin group (63.9±3.73 mmHg, P value=0.011). 
Cathecolamines and vasodilator requirement showed no remarkable difference. Intraoperative 
blood loss was lower in 5% albumin group with mean of 1425.33 (±451.81) mL whereas in 
4% gelatin group 1514.44 (±697.67) mL but the difference was not significant(P value= 
0.658). Intraoperatively, less blood transfusion was required in 5% albumin group(22.2%) 
compared to 4% gelatin group (43.8%)  
 
xi 
 
 Conclusion: Administration of 5% albumin and 4% gelatin in patients undergoing CABG 
showed no remarkable difference on renal function parameters, haemodynamic stability and 
blood loss 
Keywords: Cardiopulmonary bypass, Albumin, Gelatin, Renal Function, Blood loss 
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2.2: INTRODUCTION  
Coronary artery bypass grafting (CABG) is a major surgery that is associated 
with significant alteration in the renal function in which the incidence of acute kidney 
injury (AKI) can be as high as 30% postoperatively with approximately 1% of the 
patient requires lifelong renal replacement therapy. This in turn is related with 
considerable morbidity and mortality including prolonged intensive care and hospital 
stay (1). 
 It is postulated that the pathogenesis of AKI includes various factors; 
haemodynamic, inflammatory and nephrotoxic factors that interact with one another 
causing debilitating kidney function. Among the risk factors related to AKI following 
cardiac surgery are female gender, patients with pre-existing co-morbidities such as 
chronic obstructive airway disease (COAD), diabetes, peripheral vascular disease, renal 
insufficiency, congestive heart failure, left ventricular ejection fraction of less than 
35%, emergency surgery, cardiogenic shock needing intra aortic balloon pump (IABP) 
and those with left main coronary disease (1,2,3).  
Apart from that, CABG surgery is also known to encompass haemodynamic 
instability and also massive blood loss perioperatively though the rate of incidence 
varies depending on each center and criteria of patient selected for the study. 
Multiple factors are said to attribute to all these complications including the use 
of cardiopulmonary bypass (CPB) machine and the selected intravenous fluid that is 
utilized during the surgery. Priming fluid can be divided into two types: crystalloids and 
colloids. Crystalloids which mimic plasma electrolyte concentrations can effectively 
cause haemodilution but it is lacking in oncotic activity. Colloids, on the other hand, 
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have the ability to maintain oncotic pressure and prevent tissue oedema but have been 
linked with higher incidence of allergic reactions and coagulopathy (4).  
 However, to date, no single approach in the choice of intravenous solutions has 
proven to be most effective in minimizing the complications of CABG. Hence, the 
rational of this study is to compare synthetic colloid solution; 4% gelatin (Gelofusine®) 
with 5% albumin to compare the effect of these two solution on renal parameters as well 
as  haemodynamic stability and  blood loss following a CABG surgery. 
2.3 STUDY PROTOCOL 
Documents submitted for ethical approval, ethical approval letter and amendments to 
the original study protocol are as attached in the Appendixes 
2.3.1 LITERATURE REVIEW 
Cardiac surgery with cardiopulmonary bypass (CPB) is known to induce a 
Systemic Inflammatory Response Syndrome (SIRS) that can cause complications 
such as generalized edema, Acute Respiratory Distress Syndrome (ARDS), 
coagulopathy and Acute Kidney Injury (AKI) which may significantly contribute to 
postoperative morbidity and mortality. This phenomenon is at least partly attributed 
to the decrease in metabolism due to hypothermia and exclusion from the 
pulmonary circulation where many of the inflammatory mediators are broken down 
(1). 
The incidence of acute renal failure is common after cardiac operation and is 
found to be more frequent after a complex cardiac surgery. The incidence of acute 
kidney injury is rising after a coronary artery bypass (CABG) surgery but the 
prevalence is unclear in other types of heart surgery (2). Renal injuries are serious 
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complication of CABG with CPB which can add to morbidity and mortality rate as 
well as prolonged ICU and hospital stay. 
A study done to compare the inflammatory response between crystalloids 
(Ringer’s solution) and colloids (25% albumin and 10% Hydroxyethylstarch 
(HES)), found that priming the CPB circuit with colloids might exert beneficial 
effect on inflammatory response by having less tendency for intense inflammatory 
response evidence by lower serum level of TNFα, IL-1β, IL-6 in 25% Albumin and 
HES group compared to those primed with Ringer’s Solution (3). 
Another study done showed that Albumin prime better preserves platelet 
counts than crystalloid. Albumin also favourably influences colloid oncotic 
pressure, on-bypass positive fluid balance, postoperative weight gain, and colloid 
usage. However, the clinical significance of these conclusions needs further study 
and investigation (4). 
Having said that, even though many studies have been conducted to compare 
various types of CPB machine priming fluid, there is still no conclusive evident on 
the best type of solution to be used in order to minimise the complications. 
Hence, the rational of this study is to compare synthetic colloid solution; 4% 
gelatin (Gelofusine®) with 5% albumin which is largely extracted from human 
plasma to see the changes in renal function parameters, haemodynamic stability and  
blood loss following a CABG surgery.  
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2.3.2 OBJECTIVES 
2.3.2.1  General Objectives 
To study and compare the effects of 5% albumin and 4% gelatin 
solutions on renal function, haemodynamic stability and intraoperative 
blood loss in patients undergoing Coronary Artery Bypass Grafting 
(CABG) Surgery in HUSM 
      2.3.2.2  Specific Objectives  
 To compare mean differences of glomerular markers (serum urea, 
serum creatinine and creatinine clearance, GFR) between 5% 
albumin and 4% gelatin solution 
 To compare mean differences of the tubular markers  (Fractional 
Excretion of Sodium (FeNa) between 5% albumin and 4% gelatin 
solution 
 To compare the haemodynamic stability between 5% albumin and 
4% gelatin solution 
 To compare the amount of intraoperative blood loss between 5% 
albumin and 4% gelatin solutions 
 
     2.3.3   NULL HYPOTHESIS 
 There is no difference between 5% albumin and 4% gelatin on 
the renal parameter in patients undergoing CABG in HUSM 
 There is no difference between 5% albumin and 4% gelatin on 
haemodynamic stability in patients undergoing CABG in HUSM 
 There is no difference between 5%Albumin and 4% gelatin on 
blood loss in patients undergoing CABG in HUSM   
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2.3.4  RESEARCH DESIGN    
This is a randomized single blinded prospective study.  
2.3.5 INCLUSION and EXCLUSION CRITERIA 
o Inclusion Criteria: 
 All patients scheduled for Elective CABG 
 Not on any known nephrotoxic drugs 
o Exclusion Criteria: 
 Emergency CABG 
 History of hypersensitivity to colloid 
2.3.6 SAMPLE SIZE ESTIMATION 
o Sample size for two mean independent samples are measure using PS 
software (Dupont and Plummer, 2010) 
 α = 0.05  
 power = 0.8  
 SD of Creatinine Clearance (σ) = 20 ml/min  
 Difference in population mean (δ) =20 ml/min  
 m =1 
o Calculated sample size is 17 for each group 
o Total sample size is 34 patients 
o To compensate for possible 20% dropouts, the final sample size is 42 
(n=21 for each arm) 
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2.3.7 SAMPLING METHOD 
Simple randomization will be done based on computer generated random 
number using random allocation software in which the allocation probability is 
not altered as study progress. 
Sample, n is known in advanced (n=42) 
 n/2 selected at random and assigned to 4% gelatin  and  the rest to 5% 
albumin.  
2.3.8 STUDY AREA 
 Study will be conducted in Cardiac Operation Theatre, Cardiac Intensive 
Care Unit CICU) and Cardiac High Dependency Ward (HDW) in HUSM 
Kubang Kerian 
 
2.3.9 RESEARCH TOOL 
o Intravenous solutions 4% gelatin (Gelafusine® manufactured by B. 
Braun Medical) and 5% human albumin (manufactured by 
Octapharma) 
o Standard monitoring devices already available in study area to 
monitor: 
 Blood Pressure and Pulse rate 
 Central Venous Pressure 
 Oxygen saturation 
 Temperature 
 Urine output 
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o Laboratory equipments needed for analysis of serum urea, creatinine 
and sodium, urine creatinine and sodium 
o Medical calculator to calculate the glomerular filtration rate (GFR) 
(http://nephron.com/cgi-bin/CGSI.cgi) 
o Data collection form: Details are as Attached in Appendixes 
 
2.3.10 DATA COLLECTION METHOD 
The study was approved by the ethical committee of HUSM. Informed 
consent was obtained from the patient who met the inclusion criteria listed. 
Baseline preoperative vital signs, urine and blood tests as listed in the data 
collection sheet were taken in the ward prior to the scheduled operation  
Patients were randomly assigned to either 5% albumin or 4% gelatin  
solution group based on the computer generated randomisation sequence. 
Upon arrival to the operation theatre, pre-induction vital signs (blood 
pressure, pulse rate, oxygen saturation level will be taken as baseline. Large 
bore intravenous lines (18G and above), two arterial lines ( a 20G in a 
peripheral artery and another 16G in femoral artery) and a 7F size central 
venous catheter (CVP) in internal jugular vein will be established. 
Patient was given a standardized induction agent of midazolam, 
propofol, fentanyl and rocuronium based on their bodyweight and 
sevoflurane will be used as maintenance of anaesthesia. Intubation was done 
in the usual manner. Intravenous tranexamic acid 2 gram was given as bolus 
and another 2 gram was added into the priming fluid in all patients. All 
patients also received calculated dose of prophylactic antibiotics prior to the 
start of surgical incision.  
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Weight related dose of heparin was given to patient prior to starting CPB 
when ordered by the surgeon (300-400unit/kg). Ringer’s lactated 1000ml 
was used to prime the Cardiopulmonary bypass (CPB) machine circuit 
PLUS 500ml of 10% mannitol PLUS 500ml of either 5% albumin or 4% 
gelatin. Patients only received either 5% albumin or 4% gelatin as volume 
replacements intraoperatively to keep the central venous pressure (CVP) of 8 
to 14 mmHg. 
Mean Arterial Blood Pressure (MAP) was keep within the range of 50 to 
80 mmHg by adding cathecolamines when necessary. Cold crystalloids 
cardioplegia were given in all cases. Blood from the CPB circuit was 
salvaged with a cell salvaged device and retransfused back to patient after 
CPB is completed. Packed red blood cells were given when the hematocrit is 
less than 30% or hemoglobin less than 10 g/dL. Estimation of blood loss 
during the operation and during postoperative day (POD) 1 and 2 will be 
estimated based on the difference in haemoglobin level. Urine and blood test 
were repeated immediately after the operation, first postoperative day 
(POD1), second postoperative day (POD2) and second day after the 
operation (POD3).  
After the surgery was completed, all patients were transferred to Cardiac 
Intensive Care Unit (CICU) where mechanical ventilation was continued 
until the patient was ready to be extubated. To maintain MAP and cardiac 
index of 2.5 to 3.0 L/min/m
2 
adrenaline, noradrenaline or dobutamine were 
given accordingly whenever indicated. Continuous infusions of either 
fentanyl or morphine were given as postoperative analgesics and was 
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converted to Patient Controlled Analgesia (PCA) once patients were 
extubated 
 
 
2.3.11 PROPOSED DATA ANALYSIS 
The completed research forms will be checked and complied. Statistical 
analyses will be conducted using SPSS version 22.0 for Windows.          
Descriptive data analyses will be used to compare the effect of 5% albumin and 
4% gelatin with renal function, hemodynamic stability and blood loss.  The 
differences were considered statistically significant when P value < 0.05  
 
 
 
 
 
 
 
 
 
 
 
11 
 
2.4 BODY OF MANUSCRIPT 
 2.4.1  INTRODUCTION  
Coronary artery bypass grafting (CABG) is a major surgery that is associated 
with significant alteration in the renal function in which the incidence of acute kidney 
injury (AKI) can be as high as 30% postoperatively with approximately 1% of the 
patient requires lifelong renal replacement therapy (1,6). A retrospective observational 
study involving over 1200 patients who had undergone CABG in a tertiary public 
hospital in Malaysia found that the incidence of acute kidney injury was 36.2% with 
5.5% of those patient required lifelong renal replacement therapy (7).This in turn is 
related with considerable morbidity and mortality including prolonged intensive care 
and hospital stay (1,6).  
 It is postulated that the pathogenesis of AKI includes various factors; 
haemodynamic, inflammatory and nephrotoxic factors that interact with one another 
causing debilitating kidney function. Among the risk factors related to AKI following 
cardiac surgery are female gender, patients with pre-existing comorbidities such as 
chronic obstructive airway disease (COAD), diabetes, peripheral vascular disease, renal 
insufficiency, congestive heart failure, left ventricular ejection fraction of less than 
35%, emergency surgery, cardiogenic shock needing intra aortic balloon pump (IABP) 
and those with left main coronary disease (1,2).  
Apart from that, CABG surgery is also known to encompass haemodynamic 
instability and also massive blood loss perioperatively though the rate of incidence 
varies depending on each center and criteria of patient selected for the study. In some 
centers, perioperative bleeding in on-pump cardiac surgery can consume as high as 10% 
to15% of the blood supply (8). 
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Multiple factors are said to attribute to all these complications including the use 
of cardiopulmonary bypass (CPB) machine and the selected intravenous fluid that is 
utilized during the surgery due to the fact that surrogate technology in CPB enable it to 
temporarily replace the physiological function of vital organs such as heart,lungs and 
kidneys (9).   
To prime the CPB circuit, generally a choice of balanced electrolyte solution 
that consist of normal plasma concentration of major blood ions were chosen (9). These 
priming fluids can be divided into two types: crystalloids and colloids. Crystalloids 
which mimic plasma electrolyte concentrations can effectively cause haemodilution but 
it is lacking in oncotic activity. Colloids, on the other hand, have the ability to maintain 
oncotic pressure and prevent tissue oedema but have been linked with higher incidence 
of anaphylactic reactions and coagulopathy (4). Some other benefits of using colloids as 
priming solution was that it was shown to induce a less intense inflammatory response 
in post CPB patients undergoing CABG (3). 
A meta analysis of randomised controlled trials involving colloids found that 
tetrastarch (130/0.4) has lesser amount of blood loss when compared to albumin but 
showed no difference in the need for blood transfusion (11). A study comparing the 
hemodynamic changes in patients who were on β-blocker between Ringer’s lactate and 
5% Albumin found that hemodynamic stability was better maintained by 5% Albumin 
(13). 
  However, to date, there is no single best approach in the choice of intravenous 
solutions that could be utilised during CABG surgery either as a priming solution for 
the CPB circuit or to be given throughout the perioperative period as required by the 
patient. There is no single choice of solituion that is superior to the other in terms of 
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having been proven to be most effective in minimizing the complications of CABG. 
Hence, the rationale of this study is to compare synthetic colloid solution; 4% gelatin 
(Gelofusine®) with 5% albumin to compare the effect of these two solution on renal 
parameters as well as  haemodynamic stability and  blood loss following a CABG 
surgery. 
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  2.4.2 METHODOLOGY   
A randomised control trial, single blinded prospective study was done involving 
total of 42 patients that was electively scheduled for CABG in HUSM during the study 
period. They were randomly divided into 2 groups using random allocation software. 
Patient is excluded from the study if they are on any known nephrotoxic drug or had a 
history of allergy to colloid or was due for an emergency CABG. 
Informed consent was obtained from the patient who met the criteria listed. 
Baseline preoperative vital signs, urine and blood tests were taken in the ward prior to 
the scheduled operation. Patients were randomly assigned to either 5% albumin (n=21) 
or 4% gelatin (n=21) solution group based on the computer generated randomisation 
sequence. This meant that patient was given either 5% albumin or 4% gelatin as priming 
solution in the cardiopulmonary bypass (CPB) machine and as intravenous fluid 
intraoperatively. 
In the operation theatre, pre-induction vital signs (blood pressure, pulse rate, 
oxygen saturation level was taken as baseline. Large bore intravenous lines (18G and 
above), two arterial lines ( a 20G in a peripheral artery and another 16G in femoral 
artery) and a 7F size central venous catheter (CVP) in internal jugular vein was 
established. Patient was given intravenous induction agents of midazolam, propofol, 
fentanyl and rocuronium based on their bodyweight and sevoflurane was used as 
maintenance of anaesthesia. Intubation was done in the usual manner. Tranexamic acid 
2 gram was given as bolus and another 2 gram is added into the priming fluid in all 
patients. All patients also received calculated dose of prophylactic antibiotics prior to 
the start of surgical incision. Weight related dose of heparin was given to patient prior 
to starting CPB when ordered by the surgeon (300-400unit/kg). Mean arterial blood 
pressure (MAP) was kept within the range of 50 to 80 mmHg and the central venous 
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pressure (CVP) was kept within the range of 8 to 14 mmHg. Cold crystalloids 
cardioplegia were given in all cases. Surgical factors were standardized in every case 
since only one cardiothoracic surgeon was involved in operating all cases. 
Blood from the CPB circuit was salvaged with a cell salvaged device and 
retransfused back to patient after CPB is completed. Packed red blood cells were given 
when the hematocrit is less than 30% or hemoglobin less than 10 g/dL. Estimation of 
blood loss during the operation and during postoperative day (POD) 1 and 2 will be 
estimated based on the difference in haemoglobin level. If blood transfusion were given 
intraoperatively, haemoglobin level pre-transfusion was taken. Urine and blood test 
were repeated immediately after the operation, on the first postoperative day (POD1), 
second postoperative day (POD2) and second day after the operation (POD3). 
After the surgery was completed, all patients were transferred to Cardiac 
Intensive Care Unit (CICU) where mechanical ventilation was continued until the 
patient was ready to be extubated. Inotropes were given to maintain MAP and cardiac 
index of 2.5 to 3.0 L/min/m
2 (
adrenaline, noradrenaline, dobutamine or milrinone) 
accordingly whenever indicated. Continuous infusions of either fentanyl or morphine 
were given as postoperative analgesics and was converted to patient controlled 
analgesia (PCA) once patients were extubated. 
 Patient was extubated when they are stable haemodynamically, axillary 
temperature was satisfactory (>36.0ºC), had adequate and good spontaneous breathing, 
not tachypnoeic and arterial blood gas parameters were satisfactory. 
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Statistical analysis  
Results were presented as mean and standard deviation (SD) or count and percentile. 
The data from the 2 groups were analysed using Independant t-test for numerical data 
and Chi Square test for categorical data. Along with that, one way and two way analysis 
of variance with repeated measures (ANOVA) and post hoc Scheffe’s test were used to 
determine the effects of group, time and group-time interaction. 
 When multiple comparisons were made on a serially measured data (e.g 
haemodynamic parameter, biochemical data) the Greenhouse-Geisser correction was 
used. Medical calculation software was used to calculate for creatinine clearance (CrCl) 
and fractional excretion of Sodium (FeNa). Differences were considered statistically 
significant when P value is <0.05. 
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2.4.3 RESULTS  
Thirty four patients underwent CABG were enrolled in this study. They were 
divided into 2 groups based on computer generated randomization sequence in which 18 
patients received 5% albumin and 16 patients received 4% gelatin solution. In general, 
majority of the patients were male with 82.4% whereas female patient constituted of 
17.6%. Mean age for 5% albumin group was 63.6 (±5.4) years, while in 4% gelatin 
group was 54.3 (±7.43) years. The mean age difference between the two groups was 
significant with the P value of <0.001 obtained using independent t-test. The other 
demographic data differences between the two group was not statistically significant as 
represented in the Table 1. 
All of the patients recruited were in American Society of Anesthesiologist 
(ASA) class III. Regarding New York Heart Association (NYHA) classification, in 5% 
albumin group 5.6% was in NYHA class 1, 66.7% in NYHA II, 27.8% was NYHA III. 
In 4% gelatin group, 37.5% was NYHA I, NYHA II class was majority with 56.3% and 
6.3% was NYHA III. As regards to coexisting diabetes mellitus (DM) and 
Hypertension, in 5% albumin group 10 patients (55.6%) and in 4% gelatin group 10 
patients (62.5%) had DM while for hypertension; 16 patients (88.9%) in 5% albumin 
group had it and 13 patients (81.3%) in 4% gelatin group had it. The P value for each 
disease showed no significant difference in its occurrence between both groups with the 
value of 0.681 and 0.648 for DM and hypertension respectively (Table 1).  
Concerning the preoperative renal function parameters; mean serum urea for 5% 
albumin group was 6.69 (±3.46) mmol and 4% gelatin group showed mean value of 
6.03 (±5.85) mmol. The mean difference of serum urea between these two groups was 
0.66 (95% CI:-2.65, 3.97) with the P value of 0.689 which is not significant (Table 2). 
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The mean serum creatinine for 5% albumin group was 136.11 (±58.46) umol/L and 
148.13 (±151.92) for 4% gelatin group. The mean difference in serum creatinine was-
12.01 (95% CI:-90.68, 66.65) with the P value of 0.748 which was not significant 
(Table 3). Mean for the Glomerular Filtration Rate (GFR) preoperatively was 49.22 
(±16.26) mL/min for 5% albumin group and 69.79 (±28.39) mL/min for 4% gelatin 
group.  The mean difference in GFR was -20.57 (95% CI:-36.50, -4.64) and the P value 
was 0.013 which was significant (Table 4). Pre-operative Fractional Excretion of 
Sodium (FeNa) that was within normal range in 5% albumin group was found in 9 
patients (50.0%) and 7 patients (43.8%) in 4% gelatin group. The rest of the patients’ 
FeNa was out of normal range (Table 5). 
Regarding of intra-operative data, mean duration of anesthesia in 5% albumin 
group was 301.4 (±74.97) minutes while in 4% gelatin group 328.9 (±42.17) minute. 
Mean duration of time patient was on cardiopulmonary bypass (CPB) in 5% albumin 
group was 114.6 (±25.25) minutes and 126.7 (±27.89) minutes. The mean duration of 
aortic cross clamp was 92.3 (±39.19) minutes in 5% albumin group and 93.9 (±20.14) 
minutes in 4% gelatin group. The average mean arterial blood pressure (MAP) was 
higher in 5% albumin group with the value of 63.9 (±3.73)mmHg while in 4% gelatin 
group was 60.0 (±4.72)mmHg and the difference was statistically significant (P value = 
0.011) (Table 6). 
 Concerning the cumulative intravenous fluid (colloid) intake and urine output 
(Table 7), in average, intraoperative fluid requirement for 5% albumin group was 
791.67(±334.86) mL and 4% gelatin group was 1390.63 (±353.18) mL . The difference 
of mean volume of colloid requirement intraoperatively between these two groups was 
significant with the P value of <0.001 in which the 5% albumin group required smaller 
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volume. However, postoperative fluid requirement on day 1 and day 2 showed no 
significant difference between both groups with the P value of 0.615 and 0.630 
respectively. Average intraoperative urine output for 5% albumin group was 842.94 
(±402.86) mL and 905.31 (±638.68) mL with the P value of 0.738. Nevertheless, on 
subsequent Day 1 and 2 after the operation, 5% albumin group showed average of 
1719.41 (±714.53) mL and 2054.53 (±666.60) mL respectively while 4% gelatin group 
produced average of 1588.25 (±701.97) mL and 2050.63 (±1031.55) mL urine output 
for day 1 and 2 respectively (Table 7). 
With reference to GFR and FeNa value that was taken: mean difference in GFR 
values that was sampled immediately after the operation and on day 1 till day 3 
postoperatively showed significant differences with P value of 0.018, 0.019,0.009 and 
0.005 with respect to the time of sampling mentioned earlier. However, the mean 
difference in GFR value on preoperative day and day 3 postoperatively was not 
statistically remarkable with P value of 0.125 (mean difference -9.43(-21.62,2.76)) 
using independent t-test (Table 8) . The mean difference in FeNa immediately post 
operation till day 3 post operation was statistically not significant between the two 
groups (Table 5). 
Regarding the requirement of cathecolamines and vasodilators, descriptive 
statistics was used to compare the two groups. In 5% albumin group (Table 9), all 18 
patients required norepinephrine infusion since the beginning of the operation, 7 
(38.8%) of them required norepinephrine only till day 1 after the operation and 6 
(33.3%) patients till second postoperative day. In total, 14 patients (87.5%) from the 4% 
gelatin group required norepinephrine throughout the operation, 2 of those patients were 
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free from the infusion on day 1 and 8 of them on day 2 post operatively. The remaining 
patients required support more than two days post-operatively (Table 10). 
 Glyceryl trinitrate (GTN) was required in majority for both groups; 16 patients 
(88.9%) and 15 patients (93.8%) in 5% albumin group and 4% gelatin group 
respectively. For epinephrine infusion, in 5% albumin group 6 patients (33.3%) required 
it and 4 patients (25.0%) in 4% gelatin group needed it. 9 patients (50.0%) and 4 
patients (25.0%) necessitate the use of dobutamine infusion in 5% albumin group and 
4% gelatin group respectively. Milrinone infusion was required by 5 patients (27.8%) in 
5% albumin group (Table 9) and by 2 patients (12.5%) in 4% gelatin group (Table 10). 
The rest of the patient needed haemodynamic support for more than two days after the 
operation. 
On the topic of intraoperative blood loss, 5% albumin group showed mean of 
1425.33 (±451.81) mL whereas in 4% gelatin group 1514.44 (±697.67) mL (Table 11). 
The mean difference for the intraoperative was -89.16 mL (95% CI: -495.21, 316.89) 
with the P value of 0.658 which signified no remarkable difference. Throughout the 
operation, 4 patients (22.2%) did not require blood transfusion in 5% albumin group 
while in 4% gelatin group, 7 patients (43.8%) was blood transfusion free. The mean 
difference of pre-operative and postoperative haemoglobin level was not significant (P 
value=0.128) being 4.75 (±1.84) g/dL in 5% albumin group and 3.84 (±1.52) g/dL in 
4% gelatin group (Table 12). 
As regards to the length of hospitalization, patients in 5% albumin group stayed 
in Cardiac intensive care unit CICU)  for an average of 6.33 (±9.43) days compared to 
4% gelatin group which was  3.75(±2.83) days. The average total hospital stay day was 
13.41 (±14.09) days for 5% albumin group and 8.38 (±2.83) days for 4% gelatin group. 
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P value for both was not significant being 0.268 and 0.167 for CICU and total hospital 
stay respectively (Table 7). 
 2.4.4  DISCUSSION  
The aim of this study was to compare the effect that 5% albumin and 4% gelatin 
that were used as priming solution and as intravenous fluid during CABG surgery on 
renal function, hemodynamic stability and blood loss.  Since CABG is a major surgery 
and is known to cause renal impairment to a certain extent, exhibit haemodynamic 
instability and major blood loss in some centres all over the world (5). In this study, the 
demographic difference between the two groups was not significant except for the mean 
age in which the patients in 4% gelatin were significantly younger with the mean age of 
54.3 years compared to 63.6 years for those in 5% albumin group (P value < 0.001). 
However, this outcome was inevitable in view of a computerised randomisation was 
done to allocate the study subject. 
In this study, we found that there was no significant different on the values of 
Serum urea and creatinine of the patients in both groups. However, mean difference in 
GFR was higher in 4% gelatin since before the operation till POD3 and those values 
were also statistically significant. This could be postulated that since renal insult during 
and post CABG was bound to occur though to a different degree, and since the pre-
operative mean GFR in 4% gelatin group was better, their values continue to be better 
post-operatively compared to 5% albumin group. 
A study was conducted involving 60 patients that aimed to  investigate the 
effects of 5% albumin and 6% HES 130/0.4 as priming solutions in on pump CABG on 
renal function and their association with coagulation, postoperative blood loss and renal 
function (5). It was found that GFR differences were statistically lower in Albumin 
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group at 24, 48 and 72 hours after the operation compared to 6% HES 130/40 group (5). 
This findings was not parallel to our study, partly could be attributed to the fact that pre-
operative GFR value was significantly lower in the 5% albumin group compared to 4% 
gelatin as proposed earlier.  
A meta-analysis of randomised trials done by on the effect of HES on bleeding 
after CPB suggested that compared with albumin which is a natural type of colloid, 
HES increased amount of bleeding, increased the rate of resternotomy to secure 
hemostasis, and transfusion of blood and blood product after cardiopulmonary bypass 
(4). This finding is similar to ours in which our synthethic colloid 4% gelatin showed 
greater amount of bleeding though the figure was not statistically significant. We also 
discovered that blood transfusion requirement in patients that received 5% albumin 
were lower compared to the other group. On the other hand, another study done 
discovered no difference between 4%gelatin and 5% albumin on their effect on 
coagulation profile, blood transfusion requirement and volume of blood loss in patients 
undergoing open heart surgery (10). Various measures and technique have been adopted 
in order to minimize the amount of blood loss including withholding Clopidogrel a few 
days prior to surgery (14) and application of topical tranexamic acid which was shown 
to reduce mediastinal bleeding and blood transfusion requirement after CABG (23).  
On the topic of haemodynamic stability, average MAP during CPB was higher 
in 5% albumin group however, in terms of inotropic usage and vasodilator requirement 
between the two groups no significant difference was found. Findings from studies that 
was previously done discovered that hemodynamic stability was better with the usage of 
5% Albumin (12,13). Having said that, there were some limitations that were associated 
with this study. Firstly, the desired calculated sample size which was 42 patient (n=21 
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in each arm) was not able to be met due to limited time frame and sampling population 
during the course of the study. In future, bigger sample size in a longer duration of 
study should be undertaken.  Secondly, patients with pre-existing renal impairment were 
not excluded from this study and this could greatly influence the results. Other than 
known nephrotoxic drugs, there are other drugs that was known to exert some degree of 
alteration in the parameters of renal function that was not studied for example ACE 
inhibitors, aminoglycosides, macrolides and diuretics and these data were not 
considered in the exclusion criteria. 
Despite all the possible complications that could arise following a CABG 
surgery, a cross sectional descriptive study done involving 69 patients showed that their 
quality of life was good after the operation (24). 
 
 
2.4.5 CONCLUSION  
This study concluded that 5% albumin and 4% gelatin had no significant 
influence on renal function markers, hemodynamic stability and degree of blood loss in 
patients undergoing coronary artery bypass grafting surgery in HUSM. 
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